Optimal Strategy for Thromboprophylaxis in Fontan Circulation: A Systematic Review and Meta-analysis with a Focus on Ethnic Differences
- 10 October 2025
- journal article
- review article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2225-2240
Abstract
Fontan circulation alters cardiovascular hemodynamics to maintain circulation using a single ventricle, which may consequently increase the risk of thromboembolism. This highlights the need for effective thromboprophylaxis strategies. This study assessed optimal thromboprophylaxis regimens for patients with Fontan circulation through a comprehensive meta-analysis of literature focused on personalized, ethnicity-based approaches. PubMed, Embase, and Cochrane Library databases were searched to identify studies reporting the thromboembolic and bleeding outcomes of patients with Fontan circulation. Thirty reports-four randomized controlled trials and 26 cohort studies-were analyzed. Aspirin (risk ratio [RR], 0.46; 95% confidence interval [CI], 0.2-1.08; p = 0.07), warfarin (RR, 0.40; 95% CI, 0.24-0.65; p < 0.001), and direct oral anticoagulants (DOACs) (RR, 0.22; 95% CI, 0.01-7.57; p = 0.4) were compared with no antithrombotic therapy, and only warfarin use resulted in a statistically significant reduction in thromboembolic risk, whereas the effects of aspirin and DOACs were not statistically significant. In the East Asian subgroup, aspirin significantly decreased thromboembolic risk, compared with no intervention (RR, 0.31; 95% CI, 0.16-0.58; p < 0.001), and was significantly more effective than warfarin (RR, 0.57; 95% CI, 0.37-0.88; p = 0.01). Bleeding risk showed no significant between-group differences. Compared with no intervention, thromboprophylaxis in patients with Fontan circulation reduces thromboembolic risk. Although our findings should be carefully interpreted because of the limited data, they indicate that aspirin may be more effective than warfarin in East Asian patients, underscoring the need for further research into ethnicity-tailored thromboprophylaxis strategies.Keywords
All Related Versions
Funding Information
- The Seoul National University Hospital (SNUH)–Lee Kun-hee Child Cancer and Rare Disease Project (grant no.: 23C-030-0100)
This publication has 48 references indexed in Scilit:
- A Multicenter, Randomized Trial Comparing Heparin/Warfarin and Acetylsalicylic Acid as Primary Thromboprophylaxis for 2 Years After the Fontan Procedure in ChildrenJACC, 2011
- Evaluation of the Extracardiac Conduit Modification of the Fontan Operation for Thrombus Formation using Magnetic Resonance ImagingHeart, Lung and Circulation, 2008
- The Fontan ProcedureCirculation, 2007
- Ethnic Differences in Coagulation Factor Abnormalities After the Fontan ProcedurePediatric Cardiology, 2006
- Risk Factors for Cerebrovascular Events Following Fontan Palliation in Patients With a Functional Single VentricleThe American Journal of Cardiology, 2005
- Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedureInternational Journal of Cardiology, 2005
- Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis)The Journal of Thoracic and Cardiovascular Surgery, 2005
- Anticoagulation and Incidence of Late Cerebrovascular Accidents Following the Fontan ProcedurePediatric Cardiology, 2004
- Prevalence of “silent” pulmonary emboli in adults after the Fontan operationJACC, 2003
- Thromboembolic complications after Fontan procedures: comparison of different therapeutic approachesThe Annals of Thoracic Surgery, 2002